Skip to main content
    X

    Xenetic Biosciences Inc (XBIO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.54
    +0.05 (+3.36%)

    Market Cap: $3.49M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Xenetic Biosciences Inc (XBIO) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Xenetic Biosciences (XBIO) has a latest price of $1.54 on Nov 17, 2026, 68.8% below its 52-week high of $4.94. Its price fell 40.8% over the past 12 months. The month-end price fell 99.6% over the 10 years through Oct 2026, a compound annual decline of 42.9%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $591.84 in Jan 2017 and its lowest $2.05 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart XBIO with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for XBIO.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 54.2%, and over 6 months it fell 46.9%. The month-end price fell 33.4% over the 3 years through Oct 2026, a compound annual decline of 12.7%.

    PeriodChange
    1 month-20.2%
    3 months-54.2%
    6 months-46.9%
    12 months-40.8%
    12 months, with dividends-40.8%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-33.4%-12.7%
    5 years-87.7%-34.3%
    10 years-99.6%-42.9%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 41.7%, and its weakest was 2019, when it fell 92.7%.

    YearCloseChange
    2026 through Oct 2026$2.05-5.5%
    2025$2.17-45.6%
    2024$3.99+15.6%
    2023$3.45+21.0%
    2022$2.85-77.9%
    2021$12.90-36.8%
    2020$20.40+41.7%
    2019$14.40-92.7%
    2018$196.88-14.5%
    2017$230.37-55.4%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 33.0% below its 50-day average of $2.30 and 45.1% below its 200-day average of $2.80.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$1.54
    52-week high$4.94-68.8%
    52-week low$1.43+7.7%
    50-day average$2.30-33.0%
    200-day average$2.80-45.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 85.6%.

    MeasureValue
    1-year beta1.55
    Largest fall, 1 year-68.1%
    Largest fall, 3 years-85.6%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About XBIO

    What is XBIO's 1-year price change?

    Xenetic Biosciences's price fell 40.8% over the past 12 months. With dividends included, the 12-month total return was -40.8%.

    What is XBIO's 5-year price change?

    Xenetic Biosciences's month-end price fell 87.7% over the 5 years through Oct 2026, a compound annual decline of 34.3%. These figures leave out dividends.

    What is XBIO's 52-week high and low?

    Xenetic Biosciences's 52-week high is $4.94 and its 52-week low is $1.43. Its latest price of $1.54 on Nov 17, 2026 is 68.8% below the high.

    What is XBIO's beta?

    Xenetic Biosciences's 1-year beta against the S&P 500 is 1.55, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 68.1%.

    Is the XBIO chart free?

    Yes. Advanced Charting for XBIO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.